Management patients side effects cyclosporine therapy cutaneous disorders Cyclosporine experimental treatment multiple inflammatory diseases presumed autoimmune origin insulin-dependent diabetes mellitus uveitis rheumatoid arthritis inflammatory bowel diseases Graves disease myasthenia gravis dermatology drug primary therapy psoriasis psoriatic arthritis alopecia areata pyoderma gangrenosum Behcet disease atopic dermatitis lichen planus dose mg/kg day cyclosporine patients concerns potential short- long-term side effects patients drug close monitoring review appropriate clinical laboratory evaluations common unusual side effects management drugs pharmacokinetics cyclosporine metabolism criteria dosage adjustments 